HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TaikiUSA Touts Preservative-Free Mascara With EcoG+ Technology

This article was originally published in The Rose Sheet

Executive Summary

EcoG+ packaging technology reduces or even eliminates the need for harsh preservatives in eye-area cosmetics and other personal-care formulas, according to TaikiUSA. The “antimicrobial resin” also offers environmental benefits firms can promote to consumers wary of parabens and other strong preservatives.

You may also be interested in...



Preservative Use At Crux Of FDA Cosmetic Microbiological Safety Meeting

At FDA’s public meeting on cosmetic microbiological safety, industry defended current practices regarding the use of preservatives in cosmetics, while the Environmental Working Group urged the agency to draft guidance on the subject.

Study "Freshens" Concerns About Chemicals In Baby Products, Campaign Says

Research identifying high rates of sensitization to formaldehyde-releasing preservatives (FRPs) among children lends credence to concerns expressed in its "Toxic Tub" report released earlier this year, the Campaign for Safe Cosmetics suggests

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel